VARIABLE VL < 400 (n=93) VL 400-10,000 n=43 VL > 10,000 (n=38) P
Total-C 193 (161, 223) 179 (158, 204) 167 (133, 186) < 0.001
LDL-C 112 (84, 136) 107 (87, 131) 96 (69, 119) 0.013
Triglycerides 160 (85, 235) 127 (75, 173) 112 (90, 212) 0.29
RLP-C 11 (7, 19) 7 (6, 13) 8 (6, 13) 0.005
NEFA (mEq/L) 0.4 (0.2, 0.5) 0.3 (0.2, 0.4) 0.3 (0.2, 0.5) 0.076
Apo-B 89 ± 24 83 ± 18 78 ± 19 0.057
Lp(a) 19 (8, 44) 22 (9, 40) 15 (3, 28) 0.19
HDL-C 40 (32, 48) 38 (29, 51) 32 (24, 38) 0.003
HDL-TG 17 (12, 24) 19 (11, 25) 17 (12, 24) 0.93
ApoA-I 129 ± 28 130 ± 30 111 ± 22 0.002
ApoA-II 36 ± 10 35 ± 9 32 ± 10 0.12
ApoE 4.5 (3.5, 5.8) 3.6 (3.1, 4.4) 3.9 (3.0, 4.6) < 0.001
Preβ-1 37 (30, 47) 38 (31, 43) 35 (22, 40) 0.17
Preβ-2 1.8 (1.1, 3.4) 2.1 (1.1, 2.6) 1.3 (0.9, 2.3) 0.12
±-1 10 (6, 17) 11 (7, 17) 9 (6, 12) 0.18
±-2 29 (23, 35) 30 (24, 36) 26 (22, 30) 0.25
±-3 21 (17, 26) 25 (19, 31) 23 (16, 28) 0.14
±-4 7 (5, 10) 7 (6, 10) 7 (5, 9) 0.40
Pre±-1 2.6 (1.0, 5.0) 2.5 (1.2, 5.2) 1.4 (0.6, 3.4) 0.11
Pre±-2 4.0 (2.5, 5.5) 3.8 (2.5, 5.5) 3.2 (1.9, 4.4) 0.26
Pre±-3 2.9 (.12, 4.1) 2.9 (2.0, 4.0) 2.2 (1.8, 4.0) 0.28
Pre±-4 1.2 (0.6, 1.6) 1.3 (0.8, 1.8) 1.0 (0. 7, 1.3) 0.27
CETP (µg/mL) 2.3 (1.9, 2.7) 2.1 (1.7, 2.5) 1.9 (1.6, 2.6) 0.37
LCAT (µg/mL) 7.6 (6.6, 8.4) 6.7 (5.8, 7.6) 6.9 (5.3, 7.7) 0.012
CETP Activity (µg/mL/hour) 0.59 (-1.42, 1.85) 0.47 (-0.72, 2.44) 0.03 (-0.57, 1.49) 0.93
LCAT Activity (µg/mL/hour) 17 (11, 27) 17(10, 27) 16 (8, 25) 0.34
Values are mg/dL or as indicated.
Normal distributed data presented as average ± SD.
Non-normal distributed data presented as median (min. and max)
Table 2b: Lipoprotein associated parameters in patients, tertiled by their viral load (VL).